Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hilar cholangiocarcinoma.

Bryan Clary1, William Jarnigan, Henry Pitt

  • 1Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. clary001@mc.duke.edu

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|March 17, 2004
PubMed
Summary

Complete surgical resection is the only hope for long-term survival in patients with hilar cholangiocarcinoma (bile duct cancer). However, this complex surgery requires specialized expertise, and most patients have unresectable disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of suprainguinal bypass for aortoiliac occlusive disease in octogenarians: A Vascular Quality Initiative analysis.

Journal of vascular surgery·2026
Same author

Youngest known case of a pancreatic perivascular epithelioid cell tumor.

JPGN reports·2026
Same author

Data and the Art of Surgical Preference Card Maintenance.

JAMA surgery·2025
Same author

When the Knife Cuts Both Ways: Fear, Guilt, and the Emotional Toll of Surgical Complications.

World journal of surgery·2025
Same author

Appendicectomy in children with uncomplicated appendicitis.

Lancet (London, England)·2025
Same author

Leveraging Lean Methodology to Improve Compliance With Work-Hour Restrictions.

JAMA surgery·2024

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hilar cholangiocarcinoma (bile duct cancer) is a rare malignancy with limited treatment options.
  • Experience with this complex tumor is concentrated in specialized centers.
  • Recent data suggest a more rational approach to patient management is emerging.

Purpose of the Study:

  • To summarize expert opinions on managing hilar cholangiocarcinoma.
  • To highlight the importance of complete resection for long-term survival.
  • To discuss challenges in treating unresectable cases.

Main Methods:

  • A panel of experienced hepatobiliary surgeons convened at a joint AHPBA-AASLD forum.
  • The panel discussed key issues in hilar cholangiocarcinoma management.

Related Experiment Videos

  • The report summarizes the panel's main points and comments.

    • Main Results:

    • Complete resection with negative margins offers the only chance for long-term survival.
    • Surgical resection of hilar cholangiocarcinomas is technically demanding.
    • Most patients present with unresectable disease, posing significant palliation challenges.

    Conclusions:

    • Complete resection is the cornerstone of curative treatment for resectable hilar cholangiocarcinoma.
    • Expertise in biliary and hepatic surgery is crucial for successful outcomes.
    • Effective palliation for unresectable hilar cholangiocarcinoma remains a major clinical challenge.